Panobinostat and Ruxolitinib In MyElofibrosis (PRIME Trial)

NCT01693601 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Myelofibrosis

Interventions

DRUG: Panobinostat
DRUG: Ruxolitinib

Sponsor

John Mascarenhas